Detailed price information for Upstream Bio Inc (UPB-Q) from The Globe and Mail including charting and trades.

The GOLD 2024/2025 reports underscore the importance of spirometry in confirming a COPD diagnosis, with a post-bronchodilator ...

The big biotech, which has made genetic medicine a focus in recent years, is paying Tessera $150 million for rights to a ...

L&T Technology Services has announced the development of a next-generation AI-powered platform for respiratory diagnostics and lung navigation. It will be debuted at RSNA 2025.

Medical equipment funded by a hospital appeal is improving care for thousands of lung patients a year. The lung function machine, which was paid for by donations to Salisbury Hospital's Stars Appeal, ...

MANTUA, Ohio (WKRC) — An Ohio man said his Amazon Alexa unit saved his life after a dangerous incident on Tuesday. According ...

Non-Cystic Fibrosis Bronchiectasis Treatment Market to Reach USD 3.5 Bn by 2035 at 5.8% CAGR, Driven by rising disease burden ...

The new framework, which classifies the severity of exacerbations of COPD based on three key factors was developed by the ...

Hospitals in Kathmandu — including Bir Hospital and TU Teaching Hospital — are overwhelmed as colder weather and rising air pollution drive up asthma, pneumonia, COPD and other respiratory cases, with ...

She told us her life changed when she sought treatment at Christ Hospital and met Dr. Duane Allen, a pulmonary and critical ...

On November 17, 2025 Formycon AG (“Formycon”) announced development of a dupilumab biosimilar, FYB208, referencing Regeneron and Sanofi’s ...

A European consortium of researchers has developed a new decision making framework for health professionals which they hope ...